← Open Payments lookup

KATHERINE BARNARD: Open Payments

NPI 1407472350 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$350 in 17 payments from 13 companies in 2025. Trend: 2023 $74 · 2024 $99 · 2025 $350

Food & beverage: $350
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation2$81
Merck Sharp & Dohme LLC2$44
Aveo Pharmaceuticals, Inc.2$35
GlaxoSmithKline, LLC.2$32
TerSera Therapeutics LLC1$31
JAZZ PHARMACEUTICALS INC.1$18
ABBVIE INC.1$18
Boston Scientific Corporation1$18
AstraZeneca Pharmaceuticals LP1$16
Incyte Corporation1$15

Products named: KISQALI, KEYTRUDA, FOTIVDA, Zoladex, ZEPZELCA, VENCLEXTA, SpaceOAR VUE System - 10mL, JEMPERLI.

Industry payments across NE — which companies pay providers there.